NCT01218711View on ClinicalTrials.gov

Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions.

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

Losartan Potassium and Hydrochlorothiazide Tablets

All Listed Sponsors
lead

Torrent Pharmaceuticals Limited

INDUSTRY

NCT01218711 - Bioequivalence Study of Losartan Potassium and Hydrochlorothiazide (100 mg / 25 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Hyzaar® (100 mg / 25 mg Tablet) [Reference Formulation, Merck & Co., Inc., USA] in Healthy Human Volunteers Under Fasting Conditions. | Biotech Hunter | Biotech Hunter